
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ABT | NYSE | USD | Real-time | |
0Q15 | London | USD | Real-time | |
ABT | Mexico | MXN | Delayed | |
ABT | Switzerland | CHF | Delayed | |
ABT | Xetra | EUR | Delayed | |
ABT | Frankfurt | EUR | Delayed | |
ABT | TradeGate | EUR | Delayed | |
ABTCL | Santiago | CLP | Delayed | |
ABT | Buenos Aires | ARS | Delayed | |
ABTT34 | BM&FBovespa | BRL | Delayed | |
ABT_KZ | KASE | USD | Delayed |
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.
Name | Age | Since | Title |
---|---|---|---|
Robert B. Ford | 47 | 2008 | Chairman of the Board, President & CEO |
Michael G. O’Grady | 57 | 2023 | Independent Director |
Michelle A. Kumbier | 55 | 2018 | Independent Director |
Michael F. Roman | 63 | 2021 | Independent Director |
Sally E. Blount | 61 | 2011 | Independent Director |
Robert J. Alpern | 72 | 2008 | Independent Director |
John G. Stratton | 61 | 2017 | Independent Director |
Nancy McKinstry | 64 | 2011 | Independent Director |
Darren Wayne McDew | 62 | 2019 | Independent Director |
Claire L. Babineaux-Fontenot | 58 | 2022 | Independent Director |
Daniel J. Starks | 68 | 2017 | Independent Director |
Patricia P. Gonzalez | 51 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review